Clinical Trials
44 trialsDP-04
AstraZeneca
GEORGIA
Ohio State University Comprehensive Cancer Center
iCaRe2
University of Nebraska
ELEPHAS-02
Elephas
LYNX-EYE
San Raffaele University
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
ASAP
Avera McKennan Hospital & University Health Center
(CLOCS-2)
Imperial College London
ELEPHAS-04
Mayo Clinic
CAMPERR
Adela, Inc
ELEPHAS-05
Elephas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Weill Medical College of Cornell University
ORACLE
Guardant Health, Inc.
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
WellSpan Health
INSPIRE
Singlera Genomics Inc.
Registry for Women Who Are At Risk Or May Have Lynch Syndrome
M.D. Anderson Cancer Center
EC_ItaLynch
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Follow-up Study of Women Evaluated and Treated for Infertility
National Institutes of Health Clinical Center (CC)
MIFADORESOL
Institut de cancérologie Strasbourg Europe
POPCORN
Centro di Riferimento Oncologico - Aviano
Guangzhou Women's Health Cohort Study (GWHCS)
Guangzhou Women and Children's Medical Center
WiZen
Technische Universität Dresden
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
PrediLynch
University Hospital, Lille
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
RWJ Barnabas Health at Jersey City Medical Center
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
M.D. Anderson Cancer Center
Chemoradiation-Induced Nausea and Emesis: Quality of Life
M.D. Anderson Cancer Center
N1
CureOne
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Data Collection Analysis Business Management
MSI in Circulatory DNA of Endometrial Cancer
Peking Union Medical College Hospital
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer
Peking Union Medical College Hospital
A Survivorship Care Plan for Gynaecological Cancer Patients
Royal Marsden NHS Foundation Trust
E3N
Institut National de la Santé Et de la Recherche Médicale, France
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
National Cancer Institute (NCI)
Combined Colon and Endometrial Cancer Screening in Women With HNPCC
M.D. Anderson Cancer Center
Study of Vaginal Dilator Use After Pelvic Radiotherapy
Memorial Sloan Kettering Cancer Center
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Memorial Sloan Kettering Cancer Center
Validation of a Nutrition Screening Tool
Royal Marsden NHS Foundation Trust